The holidays seem to bring on lots of atrial fibrillation (afib), often attributed to a condition called "Holiday Heart Syndrome", which is supposedly caused by consuming too much ...
At the American Heart Association Scientific Sessions 2011, Dr. Sanjiv Narayan presented the high success rate of the FIRM trial of focal and rotor catheter ablation for atrial fibrillation.
A recent New England Journal of Medicine article reported on the results of the ARISTOTLE trial comparing the effectiveness of apixaban and warfarin for atrial fibrillation stroke preventi
At the American Heart Association Scientific Sessions 2011, Dr. John Mandrola presented a poster on gender-specific results of atrial fibrillation ablation in a private practice setting.
Recently StopAfib.org partnered with the Cleveland Clinic to give you an opportunity to chat live with two of their atrial fibrillation experts, Dr. Walid Saliba and Dr.
The US Food and Drug Administration has approved Xarelto (rivaroxaban) to reduce stroke risk in those with non-valvular atrial fibrillation (afib unrelated to heart valve problems).
The Preventive Cardiovascular Nurses Association (PCNA), in partnership with WomenHeart, Mended Hearts and The Society for Cardiac Angiography and Interventions, will host free heart ...
In this important video interview at Venice Arrhythmias, Professor Gregory Lip discusses the importance of the CHA2DS2-VASc scoring tool for predicting atrial fibrillation stroke risk ...